Ceriello A Thiazolidinediones as anti-inflammatory and anti-atherogenic agents Diabetes Metab Res Rev 2008 24 1 14 26 10.1002/dmrr.790 Ceriello A. Thiazolidinediones as anti-inflammatory and anti-atherogenic agents[J]. Diabetes Metab Res Rev, 2008, 24(1): 14-26.DOI: 10.1002/dmrr.790

Lagna G Ku M M Nguyen P H Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors J Biol Chem 2007 282 51 37244 37255 10.1074/jbc.M708137200 Lagna G, Ku M M, Nguyen P H, et al . Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors[J ] . J Biol Chem, 2007, 282(51): 37244-37255.DOI: 10.1074/jbc.M708137200

Lin G Chow S Lin J Effect of cell passage and density on protein kinase G expression and activation in vascular smooth muscle cells J Cell Biochem 2004 92 1 104 112 10.1002/jcb.20043 Lin G, Chow S, Lin J, et al . Effect of cell passage and density on protein kinase G expression and activation in vascular smooth muscle cells[J ] . J Cell Biochem, 2004, 92(1): 104-112. DOI: 10.1002/jcb.20043

Yoshida T Owens G K Molecular determinants of vascular smooth muscle cell diversity Circ Res 2005 96 3 280 291 10.1161/01.RES.0000155951.62152.2e Yoshida T, Owens G K. Molecular determinants of vascular smooth muscle cell diversity[J]. Circ Res, 2005, 96(3): 280-291.DOI: 10.1161/01.RES.0000155951.62152.2e

Zhang Z Wang M Fan X H Upregulation of TRPM7 channels by angiotensin Ⅱ triggers phenotypic switching of vascular smooth muscle cells of ascending aorta Circ Res 2012 111 9 1137 1146 10.1161/CIRCRESAHA.112.273755 Zhang Z, Wang M, Fan X H, et al . Upregulation of TRPM7 channels by angiotensin Ⅱ triggers phenotypic switching of vascular smooth muscle cells of ascending aorta[J ] . Circ Res, 2012, 111(9):1137-1146.DOI:10.1161/CIRCRESAHA.112.273755

Lim S Park S Erratum: Role of vascular smooth muscle cell in the inflammation of atherosclerosis BMB Rep 2016 49 2 134 https://www.researchgate.net/profile/Soyeon_Lim/publication/259586339_Role_of_vascular_smooth_muscle_cell_in_the_inflammation_of_atherosclerosis/links/53e02b2b0cf27a7b830a3756.pdf?origin=publication_detail Lim S, Park S. Erratum: Role of vascular smooth muscle cell in the inflammation of atherosclerosis[J]. BMB Rep, 2016, 49(2): 134.

Gao D Hao G Meng Z Rosiglitzone suppresses angiotensin Ⅱ-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells PLoS One 2015 10 4 e0123724 10.1371/journal.pone.0123724 Gao D, Hao G, Meng Z, et al . Rosiglitzone suppresses angiotensin Ⅱ-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells[J ] . PLoS One, 2015, 10(4):e0123724.DOI:10.1371/journal.pone.0123724

Iglarz M Touyz R M Amiri F Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension Arterioscler Thromb Vasc Biol 2003 23 1 45 51 10.1161/01.ATV.0000047447.67827.CD Iglarz M, Touyz R M, Amiri F, et al . Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension[J ] . Arterioscler Thromb Vasc Biol, 2003, 23(1): 45-51.DOI: 10.1161/01.ATV.0000047447.67827.CD

Silva-Junior Gde O Torres Tda S Mendonca Lde S Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats Exp Toxicol Pathol 2011 63 1/2 1 7 10.1016/j.etp.2009.09.001 Silva-Junior Gde O, Torres Tda S, Mendonca Lde S, et al . Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats[J ] . Exp Toxicol Pathol, 2011, 63(1/2): 1-7. DOI:10.1016/j.etp.2009.09.001

Qin H D Huang D Weng X D Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury J Cell Physiol 2009 221 2 387 393 10.1002/jcp.21865 Qin H D, Huang D, Weng X D, et al . Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury[J ] . J Cell Physiol, 2009, 221(2): 387-393.DOI: 10.1002/jcp.21865

Gizard F Bruemmer D Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases PPAR Res 2008 2008 429123 10.1155/2008/429123 Gizard F, Bruemmer D. Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases[J]. PPAR Res, 2008, 2008: 429123.DOI: 10.1155/2008/429123

杨 源瑞 郑 波 周 振华 猪颈动脉支架植入术后PPAR- γ 的表达变化及对血管平滑肌表型转化的影响 第三军医大学学报 2014 36 4 321 325 http://aammt.tmmu.edu.cn/oa/DArticle.aspx?type=view&id=201309139 杨源瑞, 郑波, 周振华, 等.猪颈动脉支架植入术后PPAR- γ 的表达变化及对血管平滑肌表型转化的影响[J ] .第三军医大学学报, 2014, 36(4): 321-325. DOI:10.16016/j.1000-5404.2014.04.011

Kim J S Kim I K Lee S Y Anti-proliferative effect of rosiglitazone on angiotensin Ⅱ-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway Cell Biol Int 2012 36 3 305 310 10.1042/CBI20100524 Kim J S, Kim I K, Lee S Y, et al . Anti-proliferative effect of rosiglitazone on angiotensin Ⅱ-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway[J ] . Cell Biol Int, 2012, 36(3): 305-310.DOI: 10.1042/CBI20100524

Ji Y Liu J Wang Z PPARgamma agonist, rosiglitazone, regulates angiotensin Ⅱ-induced vascular inflammation through the TLR4-dependent signaling pathway Lab Invest 2009 89 8 887 902 10.1038/labinvest.2009.45 Ji Y, Liu J, Wang Z, et al . PPARgamma ag onist, rosiglitazone, regulates angiotensin Ⅱ-induced vascular inflammation through the TLR4-dependent signaling pathway[J ] .Lab Invest, 2009, 89(8): 887-902. DOI:10.1038/labinvest.2009.45

Chen H F Xie L D Xu C S The signal transduction pathways of heat shock protein 27 phosphorylation in vascular smooth muscle cells Mol Cell Biochem 2010 333 1/2 49 56 10.1007/s11010-009-0203-5 Chen H F, Xie L D, Xu C S. The signal transduction pathways of heat shock protein 27 phosphorylation in vascular smooth muscle cells[J]. Mol Cell Biochem, 2010, 333(1/2): 49-56.DOI: 10.1007/s11010-009-0203-5

Ayari H Legedz L Cerutti C Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma J Mol Med (Berl) 2014 92 11 1201 1208 10.1007/s00109-014-1193-7 Ayari H, Legedz L, Cerutti C, et al . Mutual amplification of corticosteroids and angiotens in systems in human vascular smooth muscle cells and carotid atheroma[J ] . J Mol Med (Berl), 2014, 92(11):1201-1208.DOI:10.1007/s00109-014-1193-7

Sabri A Levy B I Poitevin P Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin Ⅱ Arterioscler Thromb Vasc Biol 1997 17 2 257 264 10.1161/01.ATV.17.2.257 Sabri A, Levy B I, Poitevin P, et al . Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin Ⅱ[J ] . Arterioscler Thromb Vasc Biol, 1997, 17(2): 257-264.

Yi B Cui J Ning J N Over-expression of PKGIalpha inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling Gene 2012 492 2 354 360 10.1016/j.gene.2011.11.010 Yi B, Cui J, Ning J N, et al . Over-expression of PKGIalpha inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling[J ] .Gene, 2012, 492(2):354-360.DOI:10.1016/j.gene.2011.11.010

Sugawara A Takeuchi K Uruno A Transcriptional suppression of type 1 angiotensin Ⅱ receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells Endocrinology 2001 142 7 3125 3134 10.1210/endo.142.7.8272 Sugawara A, Takeuchi K, Uruno A, et al . Transcriptional suppression of type 1 angiotensin Ⅱ receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells[J ] . Endocrinology, 2001, 142(7): 3125-3134.DOI: 10.1210/endo.142.7.8272

Takeda K Ichiki T Tokunou T Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin Ⅱ type 1 receptor in vascular smooth muscle cells Circulation 2000 102 15 1834 1839 10.1161/01.CIR.102.15.1834 Takeda K, Ichiki T, Tokunou T, et al . Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin Ⅱ type 1 receptor in vascular smooth muscle cells[J ] . Circulation, 2000, 102(15): 1834-1839.

Gao D F Niu X L Hao G H Rosiglitazone inhibits angiotensin Ⅱ-induced CTGF expression in vascular smooth muscle cells-role of PPAR-gamma in vascular fibrosis Biochem Pharmacol 2007 73 2 185 197 10.1016/j.bcp.2006.09.019 Gao D F, Niu X L, Hao G H, et al . Rosiglitazone inhibits angiotensin Ⅱ-induced CTGF expression in vascular smooth muscle cells-role of PPAR-gamma in vascular fibrosis[J ] . Biochem Pharmacol, 2007, 73(2): 185-197. DOI:10.1016/j.bcp.2006.09.019

Sugawara A Takeuchi K Uruno A Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin Ⅱ type 1 receptor genes Hypertens Res 2001 24 3 229 233 10.1291/hypres.24.229 Sugawara A, Takeuchi K, Uruno A, et al . Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin Ⅱ type 1 receptor genes[J ] . Hypertens Res, 2001, 24(3): 229-233.

Yi B Cui J Ning J N Over-expression of PKGIalpha inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling Gene 2012 492 2 354 360 10.1016/j.gene.2011.11.010 Yi B, Cui J, Ning J N, et al . Over-expression of PKGIalpha inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling[J ] . Gene, 2012, 492(2): 354-360. DOI:10.1016/j.gene.2011.11.010

Yang H M Kim B K Kim J Y PPAR γ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury Exp Mol Med 2013 45 11 e65 10.1038/emm.2013.112 Yang H M, Kim B K, Kim J Y, et al . PPAR γ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury[J ] . Exp Mol Med, 2013, 45(11): e65.DOI: 10.1038/emm.2013.112

Krentz A Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications Diabetes Metab Res Rev 2009 25 2 112 126 10.1002/dmrr.937 Krentz A. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications[J]. Diabetes Metab Res Rev, 2009, 25(2): 112-126.DOI: 10.1002/dmrr.937

Home P D Pocock S J Beck-Nielsen H Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 2009 373 9681 2125 2135 10.1016/S0140-6736(09)60953-3 Home P D, Pocock S J, Beck-Nielsen H, et al . Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial[J ] . Lancet, 2009, 373(9681):2125-2135.DOI:10.1016/S0140-6736(09)60953-3